Minimal and best linear combination of oxidative stress and antioxidant biomarkers to discriminate cardiovascular disease

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 12, Issue 5, 2002, Pages 259-266

  Schisterman, E F ^a,c   Faraggi, D ^b   Browne, R ^a   Freudenheim, J ^a   Dorn, J ^a   Muti, P ^a   Armstrong, D ^a   Reiser, B ^b   Trevisan, M ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF HAIFA   (Israel)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Atherosclerosis; Cardiovascular disease; Discriminant analysis; Free radicals; ROC curve; TBARS

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; FREE RADICAL; HIGH DENSITY LIPOPROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; URIC ACID;

ADULT; AGED; ARTICLE; BLOOD; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; OXIDATIVE STRESS; PHYSIOLOGY; ROC CURVE; UNITED STATES;

ADULT; AGED; ANTIOXIDANTS; BIOLOGICAL MARKERS; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FREE RADICALS; HUMANS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; NEW YORK; OXIDATIVE STRESS; ROC CURVE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; URIC ACID;

EID: 0037945785     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Hoffman RM, Garewal HS (1995) Antioxidants and the prevention of coronary heart disease. Arch Intern Med 155: 241-246
2. Schisterman EF, Faraggi D, Browne R, Freudenheim J, Dorn J, Muti P, Armstrong D, Reiser B, Trevisan M (2001) TBARS and cardiovascular disease in a population-based sample. J Cardiovasc Risk 8: 219-225
3. Chait A (1994) Low-density lipoprotein oxidation and the pathogenesis of atherosclerosis. West J Med 160: 183-184
4. Browne RW, Armstrong D (2000) HPLC analysis of lipid-derived polyunsaturated fatty acid peroxidation products in oxidatively modified human plasma. Clin Chem 46: 829-836
5. Gidez LI, Miller GJ, Burstein M, Slagle S, Elder HA (1982) Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res 23: 1206-1223
6. Hissen P, Hilf R (1976) A fluorometric method for the determination of oxidized and reduced glutathione in tissues. Anal Biochem 74: 214-226
7. Bompart GJ, Prevot DS, Bascands JL (1990) Rapid automated analysis of glutathione reductase, peroxidase, and S-transferase activity: application to cisplatin-induced toxicity. Clin Biochem 23: 501-504
8. Miller NJ, Rice-Evans C, Davies MJ (1993) A new method for measuring antioxidant activity. Biochem Soc Trans 21: 95S
9. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A (1993) A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci (Lond) 84: 407-412
10. Peters TJr, Biamonte GT, Doumas BT (1982) Protein (total protein) in serum, urine, and cerebrospinal fluid; albumin in serum. In: Faulkner W, Meites S (eds) Selected Methods of Clinical Chemistry. American Association of Clinical Chemistry, Washington
11. Armstrong D, Browne R (1994) The analysis of free radicals, lipid peroxides, antioxidant enzymes and compounds related to oxidative stress as applied to the clinical chemistry laboratory. Adv Exp Med Biol 366: 43-58
12. Westgard JO, Groth T (1981) Design and evaluation of statistical control procedures: applications of a computer "quality control simulator" program. Clin Chem 27: 1536-1545
13. Westgard JO, Barry PL, Hunt MR, Groth T (1981) A multi-rule Shewhart chart for quality control in clinical chemistry. Clin Chem 27: 493-501
14. Westgard JO (1981) Precision and accuracy: concepts and assessment by method evaluation testing. Crit Rev Clin Lab Sci 13: 283-330
15. Neter J, Wasserman W, Kutnar MH (1985) Applied linear statistical models: regression, analysis of variance, and experimental designs. RD Irwin, Homewood
16. Su JK, Liu LS (1993) Linear combinations of multiple diagnostic markers. J Am Stat Ass 88: 1350-1355
17. Kramar A, Faraggi D, Fortune A, Reiser B (2001) mROC: a computer program for combining tumour markers in predicting disease states. Comput Methods Programs Biomed 66: 199-207
18. Kramar A, Faraggi D, Ychou M, Reiser B, Grenier J (1999) [Generalized ROC criteria in the evaluation of several tumor markers]. Rev Epidemiol Sante Publique 47: 376-383
19. Reiser B, Faraggi D (1997) Confidence intervals for the generalized ROC criterion. Biometrics 53: 644-652
20. Dubois F, Belleville F (1988) [Selenium: physiologic role and value in human pathology]. Pathol Biol (Paris) 36: 1017-1025
21. Lusis AJ, Navab M (1993) Lipoprotein oxidation and gene expression in the artery wall. New opportunities for pharmacologic intervention in atherosclerosis. Biochem Pharmacol 46: 2119-2126
22. Navab M, Berliner JA, Watson AD, Hama SY, Territo MC, Lusis AJ, Shih DM, Van Lentern BJ, Frank JS, Demer LL, Edwards PA, Fogelman AM (1996) The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscler Thromb Vasc Biol 16: 831-842
23. Shah PK, Kaul S, Nilsson J, Cercek B (2001) Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part I. Circulation 104: 2376-2383
24. Zweier JL, Kuppusamy P, Lutty GA (1988) Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues. Proc Natl Acad Sci USA 85: 4046-4050
25. Ashraf M, Samra ZQ (1993) Subcellular distribution of xanthine oxidase during cardiac ischemia and reperfusion: an immunocytochemical study. J Submicrosc Cytol Pathol 25: 193-201
26. Mihailovic MB, Avramovic DM, Jovanovic IB, Pesut OJ, Matic DP, Stojanov VJ (1998) Blood and plasma selenium levels and GSH-Px activities in patients with arterial hypertension and chronic heart disease. J Environ Pathol Toxicol Oncol 17: 285-289
27. Sacks FM, Tonkin AM, Craven T, Pfeffer MA, Shepherd J, Keech A, Furberg CD, Braunwald E (2002) Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors. Circulation 105: 1424-1428
28. Buczynski A, Wachowicz B, Kedziora-Kornatowska K, Tkaczewski W, Kedziora J (1993) Changes in antioxidant enzymes activities, aggregability and malonyldialdehyde concentration in blood platelets from patients with coronary heart disease. Atherosclerosis 100: 223-228
29. Bridges AB, McNeill GP, Pringle TH, Belch JJ (1995) A late increase in free radical activity post myocardial infarction. Eur Heart J 16: 899-902
30. Bridges AB, McNeill GP, Pringle TH, Niblock A, Belch JJ (1993) Free radical markers in patients with angina pectoris and normal coronary angiograms. Cardiology 82: 7-11
31. Bridges AB, Scott NA, Pringle TH, McNeill GP, Belch JJ (1992) Relationship between the extent of coronary artery disease and indicators of free radical activity. Clin Cardiol 15: 169-174.
32. Betteridge DJ (1989) High density lipoprotein and coronary heart disease. BMJ 298: 974-975
33. Puddu PE, Lanti M, Menotti A, Mancini M, Zanchetti A, Cirillo M, Angeletti M, Panarelli W (2001) Serum uric acid for short-term prediction of cardiovascular disease incidence in the Gubbio population Study. Acta Cardiol 56: 243-251
34. Culleton BF, Larson MG, Kannel WB, Levy D (1999) Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 131: 7-13
35. Jayakumari N, Ambikakumari V, Balakrishnan KG, Iyer KS (1992) Antioxidant status in relation to free radical production during stable and unstable anginal syndromes. Atherosclerosis 94: 183-190
36. Duthie GG, Arthur JR, Beattie JA, Brown KM, Morrice PC, Robertson JD, Shortt CT, Walker KA, James WP (1993) Cigarette smoking, antioxidants, lipid peroxidation, and coronary heart disease. Ann N Y Acad Sci 686: 120-129
37. Miwa K, Igawa A, Nakagawa K, Hirai T, Inoue H (1999) Consumption of vitamin E in coronary circulation in patients with variant angina. Cardiovasc Res 41: 291-298
38. Miwa K, Miyagi Y, Fujita M (1995) Susceptibility of plasma low density lipoprotein to cupric ion-induced peroxidation in patients with variant angina. J Am Coll Cardiol 26: 632-638
39. Miller NJ, Johnston JD, Collis CS, Rice-Evans C (1997) Serum total antioxidant activity after myocardial infarction. Ann Clin Biochem 34: 85-90
40. Ames BN, Cathcart R, Schwiers E, Hochstein P (1981) Uric acid provides an antioxidant defense in humans against oxidant-and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A 78: 6858-6862
41. Sevanian A, Davies KJ, Hochstein P (1991) Serum urate as an antioxidant for ascorbic acid. Am J Clin Nutr 54: 1129S-1134S
42. Phillips SJ, Whisnant JP, O'Fallon WM, Frye RL (1990) Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota. Mayo Clin Proc 65: 344-359